SCHEMBL18159145

CC(=O)N[C@H]1C([C@H](O)[C@H](O)CO)O[C@](OC=O)(O[C@@H]2C(O)[C@H](O[C@@H]3C(CO)O[C@@H](OC(C)(C)C)C(O)[C@H]3O)OC(CO)[C@@H]2O[C@H]2OC(CO)[C@H](O)[C@H](O[C@@H]3OC(CO)[C@H](O)[C@H](O)C3O[C@@H]3OC(C)[C@@H](O)[C@H](O)C3O)C2C)C[C@H]1O

nearest known ligand 0.54

Predicted protein targets (top 5)

	gene	UniProt	supporting neighbours	confidence
▸	SELL	P14151	2/20	0.51

▸	SELP	P16109	2/20	0.51

▸	SELE	P16581	5/20	0.49

▸	MAG	P20916	6/20	0.46

▸	SIGLEC7	Q9Y286	5/20	0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
SCHEMBL18165662	0.92	SELL (0.52)	SELLSELPSELEMAGSIGLEC7
SCHEMBL25988209	0.89	SELL (0.53)	SELLSELPSELEMAGSIGLEC7
SCHEMBL18160015	0.89	SELP (0.51)	SELLSELPSELEMAGSIGLEC7
SCHEMBL11940310	0.86	SELE (0.48)	SELLSELPSELEMAGSIGLEC7
SCHEMBL15958438	0.84	SELE (0.49)	SELLSELPSELEMAGSIGLEC7
SCHEMBL15479589	0.83	SELE (0.53)	SELLSELPSELEMAGSIGLEC7
SCHEMBL17586055	0.82	SELE (0.52)	SELLSELPSELEMAGSIGLEC7
SCHEMBL21969174	0.82	SELP (0.67)	SELLSELPSELEMAGSIGLEC7
SCHEMBL4119673	0.81	MAG (0.48)	SELLSELPSELEMAGSIGLEC7
SCHEMBL17195861	0.81	MAG (0.48)	SELLSELPSELEMAGSIGLEC7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
US-20160304858-A1	DIRECTED EVOLUTION OF MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO TARGET PROTEINS	BRANDEIS UNIVERSITY	2016-10-20	—	—	US	disclosed
US-20160304628-A1	MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO TARGET PROTEINS	NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT	2016-10-20	—	—	US	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20160304628-A1	MULTIVALENT GLYCOPEPTIDES THAT TIGHTLY BIND TO TARGET PROTEINS	SIGLEC7, SIGLEC9, STT3A	SELL 461/4885SELP 248/4885SELE 202/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.